☆ 4.6 Letter

RAS mutation status and bortezomib therapy for relapsed multiple myeloma

BRITISH JOURNAL OF HAEMATOLOGY (2015)

Get Full Text
Add to Collection

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 169, Issue 6, Pages 905-908

Publisher

WILEY-BLACKWELL
DOI: 10.1111/bjh.13258

Keywords

multiple myeloma; RAS mutation; bortezomib; prognosis

Categories

Hematology

Funding

  1. Cancer Research UK [15680] Funding Source: researchfish
  2. The Francis Crick Institute [10071, 10074, 10070] Funding Source: researchfish

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.